Blues plans, Lumeris align to acquire NaviNet

Three U.S. Blue health plans are partnering with health IT provider Lumeris to acquire NaviNet, developer of communication networks for physicians, hospitals and health insurers.

Lumeris and the three Blues—Highmark, Horizon Blue Cross Blue Shield of New Jersey and Independence Blue Cross—have signed an agreement to acquire NaviNet for an undisclosed price.

The partnership will build on NaviNet's network for transactions among healthcare providers and insurers by launching an initiative to deliver critical information and applications to drive value-based healthcare. Through the new partnership, NaviNet will leverage its communication network and Lumeris' accountable care delivery platform to ease the adoption of new accountable care models throughout the U.S.

The transaction is expected to close within 30 days, subject to customary closing conditions.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.